Veracyte, Inc. (NASDAQ:VCYT) Q3 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Veracyte Third Quarter 2024 Conference Call.
Posts Tagged ‘NASDAQ:VCYT’
Here’s Why Baron Discovery Fund Increased its Holdings in Veracyte (VCYT)
Baron Funds, an investment management company, released its “Baron Discovery Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Veracyte, Inc. (NASDAQ:VCYT) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Veracyte Second Quarter 2024 Financial Results Call. At this time, all participants are in a listen-only mode.
Veracyte (VCYT) Fell Due to a Lack of Rising Profitability
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
Veracyte, Inc. (NASDAQ:VCYT) Q1 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by and welcome to the Veracyte First Quarter 2024 Financial Results Conference Call.
What Makes Veracyte (VCYT) a Lucrative Investment?
Next Century Growth Investors, LLC, an investment Management Company, released its “Micro-Cap Strategy” fourth-quarter investor letter.
Veracyte, Inc. (NASDAQ:VCYT) Q4 2023 Earnings Call Transcript
Veracyte, Inc. misses on earnings expectations. Reported EPS is $-0.39 EPS, expectations were $-0.07. Veracyte, Inc.
Veracyte, Inc. (NASDAQ:VCYT) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Veracyte Third Quarter 2023 Financial Results Webcast.
16 Best Stocks to Buy and Hold for the Next 15 Years According to Cathie Wood’s Portfolio
In this article, we will take a look at the 16 best stocks to buy and hold for the next 15 years according to Cathie Wood's portfolio.
Veracyte, Inc. (NASDAQ:VCYT) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Veracyte Second Quarter 2023 Financial Results Conference Call. [Operator Instructions].
Veracyte, Inc. (NASDAQ:VCYT) Q1 2023 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Veracyte First Quarter 2023 Financial Results Webcast. At this time, all participants are in listen-only mode.
Veracyte, Inc. (NASDAQ:VCYT) Q4 2022 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Veracyte Fourth Quarter and Full Year 2022 Financial Results Webcast.
4 Cheap Stocks to Buy According to Cathie Wood
In this article, we discuss the 5 cheap stocks to buy according to Cathie Wood.
Cathie Wood’s Top 15 Small-Cap Stock Picks
In this article, we discuss the 10 small-cap stock picks of Cathie Wood’s 2022 portfolio.
5 Small-Cap Growth Stocks in Cathie Wood’s Portfolio
In this article, we discuss 5 small-cap growth stocks in Cathie Wood's portfolio.
10 Small-Cap Stocks to Buy According to Ken Fisher
In this article, we discuss 10 small-cap stocks to buy according to Ken Fisher.
Hedge Fund and Insider Trading News: Axon Capital, AlphaTrAI, Lone Pine Capital, Point72 Asset Management, Inclusive Capital, Veracyte Inc (VCYT), Talos Energy Inc. (TALO), and More
A US hedge fund is braving this year’s sharp decline in the value of cryptocurrencies to launch two investment strategies aimed at reducing the volatility inherent in digital...
3 Stocks to Buy According to Devesh Gandhi’s SilverArc Capital
In this article, we will discuss the top 3 stocks to buy according to Devesh Gandhi’s SilverArc Capital.
Cathie Wood’s 2022 Portfolio: 5 Small-Cap Stock Picks
In this article, we discuss the 5 small-cap stock picks of Cathie Wood's 2022 portfolio.
Cathie Wood’s 5 Stock Picks for the Next 5 Years
In this article, we discuss Cathie Wood's 5 stock picks for the next 5 years.
Is Veracyte Inc (VCYT) A Good Stock To Buy?
In this article we will take a look at whether hedge funds think Veracyte Inc (NASDAQ:VCYT) is a good investment right now.
Hedge Funds Are Piling Into Veracyte Inc (VCYT)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Should You Maintain Your Veracyte (VCYT) Position?
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Global Discovery Fund’ second quarter 2021 investor letter – a copy of which can ...
Artisan Partners: “Veracyte (VCYT) is Well-Positioned to Expand Internationally”
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Small Cap Fund’ second quarter 2021 investor letter – a copy of which can be downloaded...
Is Veracyte (VCYT) A Good Stock To Buy Now?
Baron Discovery Fund recently published its second-quarter commentary – a copy of which can be downloaded here.
Is Veracyte Inc (VCYT) Going to Burn These Hedge Funds?
At Insider Monkey, we pore over the filings of nearly 866 top investment firms every quarter, a process we have now completed for the latest reporting period.
10 Best Pharmaceutical Stocks to Buy According to Cathie Wood
In this article we discuss the 10 best pharmaceutical stocks to buy according to Cathie Wood.
Cathie Wood’s Top 5 Stock Picks Based on ARK’s Latest Portfolio Update
In this article, we discuss Cathie Wood's top 5 stock picks.
Cathie Wood’s Thoughts on the Future, ARK’s Portfolio and Latest Stock Picks
In this article we will discuss Cathie Wood's latest stock picks and analyze her latest YouTube talk.
Artisan Small Cap: “Veracyte (VCYT) is Well-Positioned for a Meaningful Profit Cycle”
Artisan Partners Limited Partnership, a high value-added investment management firm, published its ‘Artisan Small Cap Fund’ fourth quarter 2020 investor letter – a copy ...
Money Supply Is Up 26%, Inflation Coming? Cathie Wood’s Bitcoin Comments and Stock Picks
In this article we talked about Cathie Wood's recent comments about money supply, inflation, interest rates, bitcoin and present Wood's top 10 small-cap stock picks.
Is VCYT A Good Stock To Buy Now?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is Veracyte Inc (VCYT) A Good Stock To Buy?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Hedge Funds Might Be Selling Veracyte Inc (VCYT), But They Are Still Bullish
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive...
Hedge Funds Have Never Been This Bullish On Veracyte Inc (VCYT)
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse of whether that stock could...
Hedge Funds Have Never Been This Bullish On Veracyte Inc (VCYT)
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Hedge Funds Have Never Been This Bullish On Veracyte Inc (VCYT)
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Veracyte Inc (VCYT): Are Hedge Funds Right About This Stock?
The successful funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous ...
13G Filing: Acuta Capital Partners Files on Veracyte, Inc. (VCYT)
A new 13G filing has been submitted to the SEC by Acuta Capital Partners, in relation to the investor's position in Veracyte Inc (NASDAQ:VCYT).
Hedge Funds Are Buying Veracyte Inc (VCYT)
Before we spend days researching a stock idea we'd like to take a look at how hedge funds and billionaire investors recently traded that stock.
Veracyte Inc (VCYT) Jumps On New Aetna Inc. (AET) Deal: Is It A Good Stock To Buy?
Veracyte Inc (NASDAQ:VCYT) shares climbed as high as $12.13 per share on Friday as the firm announced that it has signed a deal with Aetna Inc.
Clough Capital Partners Discloses 5.24% Stake In Veracyte Inc. (VCYT)
The Boston-based hedge fund Clough Capital Partners has disclosed a 5.24% passive stake of just under 1.44 million shares in Veracyte Inc.
